A child surrounded by glowing kidneys, symbolizing care and resilience in Congenital Nephrotic Syndrome.

Navigating Congenital Nephrotic Syndrome: A Comprehensive Guide for Parents and Caregivers

"Understanding, Managing, and Thriving with CNS: Insights from a Leading Dialysis Center"


Congenital Nephrotic Syndrome (CNS) is a rare and serious kidney disorder that begins in the first three months of life. Unlike other forms of nephrotic syndrome that may develop later in childhood, CNS often stems from genetic defects affecting the podocytes – specialized cells in the kidneys responsible for filtering blood. These defects disrupt the kidney's ability to retain protein, leading to significant protein loss in the urine.

One of the most severe forms of CNS is Finnish-type nephrotic syndrome (CNF), characterized by heavy proteinuria even before birth. Infants with CNF typically have extremely low levels of serum albumin and develop edema (swelling) shortly after birth. The condition poses significant challenges, requiring intensive medical management to support kidney function and overall health.

While CNS presents considerable hurdles, advances in treatment offer hope for improved outcomes. This article aims to provide families and caregivers with a comprehensive overview of CNS, drawing on the experience of a leading dialysis center to shed light on diagnosis, treatment strategies, and long-term management.

What are the Key Indicators and Diagnostic Approaches for CNS?

A child surrounded by glowing kidneys, symbolizing care and resilience in Congenital Nephrotic Syndrome.

Diagnosing CNS involves recognizing specific clinical signs and confirming them through laboratory tests. Key indicators include:

The study investigated the outcomes of 15 children (6 boys) with CNS, managed at St. Vladimir children's clinical hospital, Moscow, in 2008 - 2017 yrs. Several diagnostic approaches were used including:
  • Proteinuria: Elevated levels of protein in the urine (greater than 3 g/L).
  • Hypoalbuminemia: Low levels of albumin in the blood (less than 34 g/L). Albumin is a crucial protein that helps maintain fluid balance and transport various substances throughout the body.
  • Edema: Swelling, particularly in the abdomen, face, and extremities, due to fluid accumulation.
  • Onset Before 3 Months: Symptoms appearing before three months of age are a critical diagnostic criterion.
In some cases, genetic testing may be recommended to identify the specific gene mutation responsible for CNS. Identifying the genetic cause can help predict the course of the disease and guide treatment decisions.

Living Well with CNS: Hope for the Future

While CNS presents significant challenges, early diagnosis, comprehensive treatment, and ongoing support can significantly improve outcomes for affected children. The study highlights the importance of conservative therapies, dialysis, and kidney transplantation in enabling many patients to survive and lead fulfilling lives. Continued research and advancements in medical care offer hope for even better outcomes for children with CNS in the future.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.